Healthy Term Infants
7
0
0
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
28.6%
2 terminated out of 7 trials
71.4%
-15.1% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life
The Combiotic-Study
Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.
Growth and Safety of a Low Lactose Milk-Based Infant Formula
Tolerance of Healthy Term Infants Fed Infant Formulas #4
Growth and Tolerance of Healthy Term Infants to a New Infant Formula
The Evaluation of Cow's Milk Formula - Study B